AstraZeneca and Daiichi Sankyo's Enhertu Shows Positive Results in Phase III Study
CompanyDrug

AstraZeneca and Daiichi Sankyo’s Enhertu Shows Positive Results in Phase III Study

Boehringer Ingelheim Appeals CNIPA's Invalidation of Jardiance Patents
Company

Boehringer Ingelheim Appeals CNIPA’s Invalidation of Jardiance Patents

Genentech's TNKase Approved by FDA for Acute Ischemic Stroke Treatment
CompanyDrug

Genentech’s TNKase Approved by FDA for Acute Ischemic Stroke Treatment

Eisai's Lecanemab Rejected by Australia's TGA for Early Alzheimer's Treatment
CompanyDrug

Eisai’s Lecanemab Rejected by Australia’s TGA for Early Alzheimer’s Treatment

Boston Scientific to Acquire SoniVie, Boosting Hypertension Treatment Portfolio
CompanyDeals

Boston Scientific to Acquire SoniVie, Boosting Hypertension Treatment Portfolio

Fapon Biopharma's FP008 Receives FDA Approval for Clinical Trials
CompanyDrug

Fapon Biopharma’s FP008 Receives FDA Approval for Clinical Trials

Kyorin Pharmaceutical Licenses KRP-M223 to Novartis for Global Development
CompanyDeals

Kyorin Pharmaceutical Licenses KRP-M223 to Novartis for Global Development

GSK's Depemokimab Accepted for FDA Review as Ultra-Long-Acting Biologic
CompanyDrug

GSK’s Depemokimab Accepted for FDA Review as Ultra-Long-Acting Biologic

Juvestar and Raziel Therapeutics Launch Phase III Study for RZL-012 in China
CompanyDrug

Juvestar and Raziel Therapeutics Launch Phase III Study for RZL-012 in China

Waters and Kehua's LC-MS Systems Gain NMPA Approval for IVD Use
CompanyMedical Device

Waters and Kehua’s LC-MS Systems Gain NMPA Approval for IVD Use

Zai Lab's Augtyro Receives TFDA Approval for ROS1-Positive NSCLC and NTRK Fusion Solid Tumors
CompanyDrug

Zai Lab’s Augtyro Receives TFDA Approval for ROS1-Positive NSCLC and NTRK Fusion Solid Tumors

Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital
CompanyDeals

Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital